April 16, 2020 Clinical Research/Diagn. Informatics & Software Lab Top-10

Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to... Read more

April 15, 2020 Clinical Research/Diagn. Product Launch

QIAGEN launches therascreen BRAF test as companion diagnostic to a BRAFTOVI® (encorafenib) based regimen in metastatic colorectal cancer

Germantown, Maryland, and Hilden, Germany, April 15 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced launch of its novel therascreen® BRAF V600E RGQ PCR Kit (therascreen BRAF V600E Kit) following U.S. Food and Drug Administration (FDA) approval as a companion diagnostic to the BRAF inhibitor, BRAFTOVI® (encorafenib), which the FDA has... Read more

April 13, 2020 Clinical Research/Diagn. Life Science Tools

BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use

New Test Uses BD MAX™ System to Augment Supply from Existing Collaborations; Test Results in Under Three HoursApr 13, 2020 FRANKLIN LAKES, N.J., April 13, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)... Read more

April 13, 2020 Clinical Research/Diagn. Product Launch

Release of the “2019 Novel Coronavirus Detection Kit”Reduces labor and halves detection time

Shimadzu Corporation is announcing the release of its “2019 Novel Coronavirus Detection Kit”, with sales beginning on 20th April. For the time being the kits will only be available in Japan, but preparations are underway to export these kits overseas from May onwards. Current PCR methods for the detection of the novel coronavirus (SARS-CoV-2) require... Read more

April 11, 2020 Clinical Research/Diagn. M&A, Partnerships

Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat

Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat. The ANPC team, led by world-renowned phenomics pioneer and academician Professor Jeremy Nicholson, and working with the South Metropolitan Health Service COVID-19 Response Team and the broader Western Australian... Read more

April 8, 2020 Clinical Research/Diagn. Informatics & Software

Global COVID-19 Clinical Trial Tracker launched by Cytel

Caption: Global COVID-19 Clinical Trial Tracker Waltham, MA — April 08, 2020 — Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak. This will enable... Read more

April 7, 2020 Clinical Research/Diagn. Product Launch

Bio-Rad Announces the Launch of a Serology Assay to Detect Coronavirus (COVID-19) Antibodies

Date: 04/07/2020 HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company is launching a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. Preliminary performance of the assay has been established and the... Read more

April 3, 2020 Clinical Research/Diagn.

BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.

New Test Immediately Available to Increase Capacity of Rapid, On-Site Testing of COVID-19 at Hospitals Across the U.S.Apr 3, 2020 FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala. April 3, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, today announced that the U.S.... Read more

April 1, 2020 Clinical Research/Diagn. Life Science Tools

Promega GoTaq® Probe 1-Step RT-qPCR System Approved for Use in CDC’s COVID-19 Emergency Use Authorization Diagnostic Panel

Promega amplification reagent added to EUA list for laboratories that follow CDC’s testing protocols Madison, WI USA. (April 1, 2020) Promega Corporation’s GoTaq® Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus... Read more

April 1, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!

April 1, 2020 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched its new AAV stability application on the Uncle platform today. Uncle is already the gold standard for measuring protein stability and, with this new application, jumps in to support researchers in pursuit... Read more